← Leaderboards
Rebecca G. Nowak
University Of Maryland Baltimore
$3,906,171
Attributed
$5,547,568
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,547,568 · 5
By mechanism
U01$3,210,795 · 1
R01$1,161,040 · 1
K07$677,160 · 1
R21$444,573 · 1
K12$54,000 · 1
Top collaborators
- Sylvia Adebajo6 shared
- Stuart S Martin1 shared
- Taofeek K Owonikoko1 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Sylvia Adebajo$2,792,614
- Manhattan E Charurat$19,344,390
- Poonam Mathur$386,250
- Omar Harfouch$140,740
Others in their field
Other Emerging Leaders on “Cohort”
- Leonard Freedman · Leidos Biomedical Research, Inc.$70,225,348
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Scott Hensley · University Of Pennsylvania$47,346,110
- Susan M Landau · University Of California Berkeley$47,252,026
Research focus
CohortNigeriaHpv-High RiskParticipantGeneral PopulationAnusPreventMen Who Have Sex With MenCancer PreventionCancer RiskMalignant Neoplasm Of AnusLearningMultidisciplinaryTrainingEnsureDetectionMalignant NeoplasmsLesionSquamous Intraepithelial LesionEnvironmentHiv RiskVirusMediatingIncidence
Grant awards (16)
Integrated Model for the Prevention of Anal Cancer using screen and Treat for HSIL (IMPACT)$747,984
U01 · FY2025 · CA · contact PI
Characterize longitudinal events of oral high-risk human papillomavirus to alter risk for oropharyngeal cancer (CLEAR)$562,100
R01 · FY2025 · DE · contact PI
Integrated Model for the Prevention of Anal Cancer using screen and Treat for HSIL (IMPACT)$134,565
U01 · FY2025 · CA · contact PI
Advancing Oncologic Research Communities in Health Equity (ARCH) K12 Program$54,000
K12 · FY2025 · CA
Integrated Model for the Prevention of Anal Cancer using screen and Treat for HSIL (IMPACT)$727,189
U01 · FY2024 · CA · contact PI
Characterize longitudinal events of oral high-risk human papillomavirus among an at-risk population (CLEAR)$598,940
R01 · FY2024 · DE · contact PI
Engaging Leaders to Elicit Viewpoints on Anal Cancer Prevention (ELDERS) study$100,000
U01 · FY2024 · CA · contact PI
Integrated Model for the Prevention of Anal Cancer using screen and Treat for HSIL (IMPACT)$727,818
U01 · FY2023 · CA · contact PI
Integrated Model for the Prevention of Anal Cancer using screen and Treat for HSIL (IMPACT)$773,239
U01 · FY2022 · CA · contact PI
Evaluating immunity to oral human papillomavirus to understand the lower oropharyngeal cancer risk among MSM$196,931
R21 · FY2022 · DE · contact PI
Role of anal microbiota, local cytokines and HIV in persistence of high-risk human papillomavirus$135,432
K07 · FY2022 · CA · contact PI
Evaluating immunity to oral human papillomavirus to understand the lower oropharyngeal cancer risk among MSM$247,642
R21 · FY2021 · DE · contact PI
Role of anal microbiota, local cytokines and HIV in persistence of high-risk human papillomavirus$135,432
K07 · FY2021 · CA · contact PI
Role of anal microbiota, local cytokines and HIV in persistence of high-risk human papillomavirus$135,432
K07 · FY2020 · CA · contact PI
Role of anal microbiota, local cytokines and HIV in persistence of high-risk human papillomavirus$135,432
K07 · FY2019 · CA · contact PI
Role of anal microbiota, local cytokines and HIV in persistence of high-risk human papillomavirus$135,432
K07 · FY2018 · CA · contact PI